These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1134 related items for PubMed ID: 17958695
21. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration. Kazumoto T, Kato S, Tabushi K, Kutsutani-Nakamura Y, Mizuno H, Takahashi M, Shiromizu K, Saito Y. Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1157-66. PubMed ID: 17459604 [Abstract] [Full Text] [Related]
22. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution. Parker K, Gallop-Evans E, Hanna L, Adams M. Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):140-6. PubMed ID: 18922646 [Abstract] [Full Text] [Related]
23. Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience. Rath GK, Sharma DN, Julka PK, Subramani V, Bahl A, Haresh KP. Am J Clin Oncol; 2010 Jun 01; 33(3):238-41. PubMed ID: 19841576 [Abstract] [Full Text] [Related]
24. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Chargari C, Magné N, Dumas I, Messai T, Vicenzi L, Gillion N, Morice P, Haie-Meder C. Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):133-9. PubMed ID: 18774656 [Abstract] [Full Text] [Related]
25. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis. Shin KH, Huh SJ, Chie EK, Choi DR, Lim DH, Kim MK, Lee KC, Kim DY, Ahn YC. Radiat Med; 1999 May 01; 17(4):289-93. PubMed ID: 10510902 [Abstract] [Full Text] [Related]
26. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, Weitmann H, Reinthaller A, Knocke TH, Wachter S, Kirisits C. Radiother Oncol; 2007 May 01; 83(2):148-55. PubMed ID: 17531904 [Abstract] [Full Text] [Related]
28. Radical radiation therapy for adenocarcinoma of the uterine cervix. Toita T, Takizawa Y, Nakano M, Sueyama H, Kushi A, Kakihana Y, Ogawa K, Hara R, Higashi M, Sakumoto K. Strahlenther Onkol; 1994 May 01; 170(5):277-80. PubMed ID: 8197550 [Abstract] [Full Text] [Related]
30. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens. Mayer A, Nemeskéri C, Petneházi C, Borgulya G, Varga S, Naszály A. Strahlenther Onkol; 2004 Apr 01; 180(4):209-15. PubMed ID: 15057431 [Abstract] [Full Text] [Related]
31. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group). Sakata K, Sakurai H, Suzuki Y, Katoh S, Ohno T, Toita T, Kataoka M, Tanaka E, Kaneyasu Y, Uno T, Harima Y, Nakano T, Japan Radiation Oncology Study Group. Acta Oncol; 2008 Apr 01; 47(3):434-41. PubMed ID: 18348003 [Abstract] [Full Text] [Related]
38. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer. Suzuki O, Yoshioka Y, Isohashi F, Morimoto M, Kotsuma T, Kawaguchi Y, Konishi K, Nakamura S, Shiomi H, Inoue T. Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1329-34. PubMed ID: 18439763 [Abstract] [Full Text] [Related]